Literature DB >> 16362281

Troglitazone: the lesson that nobody learned?

Edwin A M Gale.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16362281     DOI: 10.1007/s00125-005-0074-6

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  7 in total

Review 1.  Lessons from the glitazones: a story of drug development.

Authors:  E A Gale
Journal:  Lancet       Date:  2001-06-09       Impact factor: 79.321

Review 2.  Between two cultures: the expert clinician and the pharmaceutical industry.

Authors:  Edwin A M Gale
Journal:  Clin Med (Lond)       Date:  2003 Nov-Dec       Impact factor: 2.659

3.  Conflict-of-interest policy at the National Institutes of Health: the pendulum swings wildly.

Authors:  Evan G DeRenzo
Journal:  Kennedy Inst Ethics J       Date:  2005-06

4.  Hepatic dysfunction associated with troglitazone.

Authors:  P B Watkins; R W Whitcomb
Journal:  N Engl J Med       Date:  1998-03-26       Impact factor: 91.245

5.  The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes.

Authors: 
Journal:  Diabetes Care       Date:  1999-04       Impact factor: 19.112

6.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.

Authors:  William C Knowler; Elizabeth Barrett-Connor; Sarah E Fowler; Richard F Hamman; John M Lachin; Elizabeth A Walker; David M Nathan
Journal:  N Engl J Med       Date:  2002-02-07       Impact factor: 91.245

7.  Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone.

Authors:  J J Nolan; B Ludvik; P Beerdsen; M Joyce; J Olefsky
Journal:  N Engl J Med       Date:  1994-11-03       Impact factor: 91.245

  7 in total
  11 in total

1.  Measuring interference of drug-like molecules with the respiratory chain: toward the early identification of mitochondrial uncouplers in lead finding.

Authors:  Ursula Stock; Hans Matter; Kerstin Diekert; Wolfgang Dörner; Stefan Dröse; Thomas Licher
Journal:  Assay Drug Dev Technol       Date:  2013-08-30       Impact factor: 1.738

2.  Risks of troglitazone apparent before approval in USA.

Authors:  J S Cohen
Journal:  Diabetologia       Date:  2006-04-07       Impact factor: 10.122

3.  Should medical journals carry drug advertising? No.

Authors:  Gareth Williams
Journal:  BMJ       Date:  2007-07-14

4.  Perception on adverse drug reaction reporting by physicians working in southern romania.

Authors:  Marian Sorin Paveliu; Simona Bengea-Luculescu; Mihai Toma; Silvia Fraga Paveliu
Journal:  Maedica (Bucur)       Date:  2013-03

5.  Collateral damage: the conundrum of drug safety.

Authors:  E A M Gale
Journal:  Diabetologia       Date:  2009-10       Impact factor: 10.122

6.  Therapy: The second time as farce: rosiglitazone and the regulators.

Authors:  Edwin A M Gale
Journal:  Nat Rev Endocrinol       Date:  2010-11-23       Impact factor: 43.330

7.  Exploring the metabolic landscape of pancreatic ductal adenocarcinoma cells using genome-scale metabolic modeling.

Authors:  Mohammad Mazharul Islam; Andrea Goertzen; Pankaj K Singh; Rajib Saha
Journal:  iScience       Date:  2022-05-30

8.  Type II diabetes mellitus and obesity: Common links, existing therapeutics and future developments.

Authors:  Subhadeep Banerjee; Indrani Talukdar; Arnab Banerjee; Arnav Gupta; Advait Balaji; Raviprasad Aduri
Journal:  J Biosci       Date:  2019-12       Impact factor: 1.826

9.  Postmarket drug surveillance without trial costs: discovery of adverse drug reactions through large-scale analysis of web search queries.

Authors:  Elad Yom-Tov; Evgeniy Gabrilovich
Journal:  J Med Internet Res       Date:  2013-06-18       Impact factor: 5.428

Review 10.  A Review on the Assessment of the Efficacy of Common Treatments in Polycystic Ovarian Syndrome on Prevention of Diabetes Mellitus.

Authors:  Sareh Dashti; Latiffah Abdul Latiff; Nor Afiah Binti Mohd Zulkefli; Anisah Binti Baharom; Halimatus Sakdiah Minhat; Habibah Abdul Hamid; Maimunah Ismail; Ali Jafarzadeh Esfehani; Azrin Shah Abu Bakar; Nur Amirah Inani Binti Sabri
Journal:  J Family Reprod Health       Date:  2017-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.